Core Insights - The article discusses the establishment of pricing for brain-computer interface (BCI) medical services in various provinces in China, highlighting the integration of these services into the healthcare system and the support from government policies [4][5][10]. Pricing and Policy Developments - The Sichuan Provincial Medical Insurance Bureau has set a maximum price for BCI services, effective from April 30, 2026, with different pricing based on hospital levels for invasive procedures [4]. - Other provinces, including Hubei, Zhejiang, and Jiangsu, have also established pricing for BCI services, with costs for invasive procedures ranging from approximately 6,000 to 6,600 yuan per procedure [5][6][7]. - The pricing structure includes insertion fees, removal fees, and adaptation fees, with some provinces incorporating non-invasive adaptation fees into insurance coverage [5][8]. Government Support and Strategic Planning - The Chinese government has outlined a strategic plan to support the BCI industry through policies that focus on planning, payment, and standards, aiming for significant advancements by 2030 [10][11]. - Multiple provinces have released action plans to promote BCI innovation and commercialization, with specific targets for clinical applications and production [11]. Technological Advancements and Market Potential - The article notes that while invasive BCI products are still in clinical trials, non-invasive products have begun to enter the market, indicating a growing application space [12]. - The industry is at a critical juncture where technological breakthroughs are expected to lead to commercial viability, supported by favorable policies and anticipated production from companies like Neuralink [15][17]. Investment Opportunities - Analysts suggest focusing on key segments of the BCI industry, including hardware suppliers, companies with core patents, and those involved in rehabilitation and industrial applications [15][16]. - Specific companies are highlighted as potential beneficiaries of the BCI market growth, including Aipeng Medical, Lepu Medical, and Xiangyu Medical, among others [16].

Core Insights - The report from Guosen Securities indicates that brain-computer interfaces (BCIs) have reached a critical juncture for transitioning from technological breakthroughs to commercial viability, anchored by the "policy + technology + scenario" framework [1] - The industry is benefiting from policy incentives such as the 14th Five-Year Plan, medical insurance coding, and the establishment of medical device standards, alongside the anticipated mass production by Neuralink and breakthroughs in domestic clinical applications, suggesting a potential explosive growth in the global market [1] Product Development - In terms of product offerings, invasive products are still in clinical trials, while non-invasive products have seen some market entry, including medical brain-computer interface systems for motor rehabilitation and consumer sleep aids [1] - With advancements in chips, electrodes, and algorithms, along with the continuous improvement of regulatory standards, it is expected that brain-computer interface products will experience intensive commercialization in the coming years [1] Investment Recommendations - The report suggests focusing on core segments of the industry chain and technological pathways, prioritizing companies with competitive advantages [1] - For upstream investments, attention should be given to hardware suppliers of EEG sensors and core chips, which will benefit from the demand surge due to equipment mass production [1] - Midstream investments should target companies with core patents and clinical resources, particularly those in the invasive sector that can benchmark against international standards and those in the non-invasive sector that can quickly implement solutions [1] - Downstream, it is advisable to track companies that form commercial closed loops in rehabilitation medicine and industrial control, while also considering synergistic opportunities in "AI + brain-computer" and "robotics + brain-computer" ecosystems [1]